GS-nitroxide (JP4-039)-mediated radioprotection of human fanconi anemia cell lines

Radiation Research

Volumn 176, Issue 5, 2011, Pages 603-612

  Bernard, Mark E ^a   Kim, Hyun ^a   Berhane, Hebist ^a   Epperly, Michael W ^a   Franicola, Darcy ^a   Zhang, Xichen ^a   Houghton, Frank ^a   Shields, Donna ^a   Wang, Hong ^a   Bakkenist, Christopher J ^b   Frantz, Marie Celine ^c   Forbeck, Erin M ^b   Goff, Julie P ^a   Wipf, Peter ^b   Greenberger, Joel S ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; FANCONI ANEMIA GROUP A PROTEIN; FANCONI ANEMIA GROUP C PROTEIN; FANCONI ANEMIA GROUP D2 PROTEIN; JP 4 039; NITROXIDE DERIVATIVE; TEMPOL; UNCLASSIFIED DRUG;

ARTICLE; CELL LINE; CONTROLLED STUDY; DNA STRAND BREAKAGE; DRUG DISTRIBUTION; DRUG EFFECT; FANCONI ANEMIA; HUMAN; HUMAN CELL; MITOCHONDRION; PRIORITY JOURNAL; RADIATION PROTECTION;

BIOLOGICAL TRANSPORT; CELL LINE; CLONE CELLS; DNA BREAKS, DOUBLE-STRANDED; FANCONI ANEMIA; FANCONI ANEMIA COMPLEMENTATION GROUP D2 PROTEIN; FANCONI ANEMIA COMPLEMENTATION GROUP G PROTEIN; GLUTATHIONE; HUMANS; MITOCHONDRIA; MITOMYCIN; NITROGEN OXIDES; RADIATION-PROTECTIVE AGENTS; TRANSGENES;

EID: 80155193821     PISSN: 00337587     EISSN: 19385404     Source Type: Journal    
DOI: 10.1667/RR2624.1     Document Type: Article

References (52)

1. Rosenberg PS, Socié G, Alter BP, Gluckman E. Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants. Blood 2005; 105:67-73. (Pubitemid 40053065)
2. Auerbach AD, Allen RG. Leukemia and preleukemia in Fanconi anemia patients. A review of the literature and report of the International Fanconi Anemia Registry. Cancer Genet Cytogenet 1991; 51:1-12.
3. Alter BP, Greene MH, Velazquez I, Rosenberg PS. Cancer in Fanconi anemia. Blood 2003; 101:2072.
4. Alter BP. Fanconi's anemia and malignancies. Am J Hematol 1996; 53:99-110. (Pubitemid 26377695)
5. D'Andrea AD. Susceptibility pathways in Fanconi's anemia and breast cancer. N Engl J Med 210; 362:1909-19.
6. Kutler DI, Singh B, Satagopan J, Batish SD, Berwick M, Giampietro PF, et al. A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 2003; 101:1249-56. (Pubitemid 36182492)
7. Masserot C, Peffault de Latour R, Rocha V, Leblanc T, Rigolet A, Pascal F, et al. Head and neck squamous cell carcinoma in 13 patients with Fanconi anemia after hematopoietic stem cell transplantation. Cancer 2008; 113:3315-22.
8. Lowy DR, Gillison ML. A new link between Fanconi anemia and human papillomavirus-associated malignancies. J Natl Cancer Inst 2003; 95:1648-50. (Pubitemid 37509065)
9. Sasaki MS, Tonomura A. A high susceptibility of Fanconi's anemia to chromosome breakage by DNA cross-linking agents. Cancer Res 1973; 33:1829-36.
10. Parmar K, Kim J, Sykes SM, Shimamura A, Stuckert P, Zhu K, et al. Hematopoietic stem cell defects in mice with deficiency of Fancd2 or Usp1. Stem Cells 2010; 28:1186-95.
11. Vinciguerra P, Godinho SA, Parmar K, Pellman D, D'Andrea AD. Cytokinesis failure occurs in Fanconi anemia pathway-deficient murine and human bone marrow hematopoietic cells. J Clin Invest 2010; 120:3834-42.
12. Auerbach AD, Rogatko A, Schroeder-Kurth TM. International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity. Blood 1989; 73:391-6. (Pubitemid 19060518)
13. Gluckman E, Devergie A, Dutreix J. Radiosensitivity in Fanconi anemia: application to the conditioning regimen for bone marrow transplantation. Br J Haematol 1983; 54:431-40. (Pubitemid 13054564)
14. Mohseni Meybodi A, Mozdarani H. DNA damage in leukocytes from Fanconi anemia (FA) patients and heterozygotes induced by mitomycin C and ionizing radiation as assessed by the comet and comet-FISH assay. Iran Biomed J 2009; 13:1-8.
15. Mohseni-Meybodi A, Mozdarani H, Vosough P. Cytogenetic sensitivity of G0 lymphocytes of Fanconi anemia patients and obligate carriers to mitomycin C and ionizing radiation. Cytogenet Genome Res 2007; 119:191-5. (Pubitemid 351235050)
16. Meetei AR, de Winter JP, Medhurst AL, Wallisch M, Waisfisz Q, van de Vrugt HJ, et al. A novel ubiquitin ligase is deficient in Fanconi anemia. Nat Genet 2003; 35:165-70. (Pubitemid 37187635)
17. Näf D, Kupfer GM, Suliman A, Lambert K, D'Andrea AD. Functional activity of the Fanconi anemia protein FAA requires FAC binding and nuclear localization. Mol Cell Biol 1998; 18:5952-60. (Pubitemid 28450546)
18. Nakanishi K, Taniguchi T, Ranganathan V, New HV, Moreau LA, Stotsky M, et al. Interaction of FANCD2 and NBS1 in the DNA damage response. Nat Cell Biol 2002; 4:913-20. (Pubitemid 35469420)
19. Wang X, Andreassen PR, D'Andrea AD. Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. Mol Cell Biol 2004; 24:5850-62. (Pubitemid 38787970)
20. Mudra KK, Morris, C, DeLaat C, Sambrano J, Masterson M, Mueller R, et al. Bone marrow transplantation in Fanconi anemia using matched sibling donors. Blood 1994; 84:2050-4. (Pubitemid 24286159)
21. Gluckman E, Auerbach AD, Horowitz MM, Sobocinski KA, Ash RC, Bortin MM, et al. Bone marrow transplantation for Fanconi anemia. Blood 1995; 86:2856-62.
22. MacMillan ML, Wagner JE. Haematopoietic cell transplantation for Fanconi anaemia - when and how? Br J Haematol 2010; 149:14-21.
23. Djuzenova CS, Rothfuss A, Oppitz U, Spelt G, Schindler D, Hoehn H, et al. Response to X-irradiation of Fanconi anemia homozygous and heterozygous cells assessed by the single-cell gel electrophoresis (comet) assay. Lab Invest 2001; 81:185-92. (Pubitemid 32176382)
24. Garcia-Higuera I, Kuang Y, Näf D, Wasik J, D'Andrea AD. Fanconi anemia proteins FANCA, FANCC, and FANCG/XRCC9 interact in a functional nuclear complex. Mol Cell Biol 1999; 19:4866-73.
25. Kuang Y, Garcia-Higuera I, Moran A, Mondoux M, Digweed M, D'Andrea AD. Carboxy terminal region of the Fanconi anemia protein, FANCG/XRCC9, is required for functional activity. Blood 2000; 96:1625-32. (Pubitemid 30661039)
26. Mirchandani KD, McCaffrey RM, D'Andrea AD. The Fanconi anemia core complex is required for efficient point mutagenesis and Rev1 foci assembly. DNA Repair (Amst) 2008; 7:902-11.
27. Rwigema JCM, Beck B, Wang W, Doemling A, Epperly MW, Shields D, et al. Two strategies for the development of mitochondrial-targeted small molecule radiation damage mitigators. Int J Radiat Oncol Biol Phys 2011; 80:860-8.
28. Epperly MW, Sikora CA, DeFilippi SJ, Gretton JA, Zhan Q, Kufe DW, et al. Manganese superoxide dismutase (SOD2) inhibits radiation-induced apoptosis by stabilization of the mitochondrial membrane. Radiat Res 2002; 157:568-77. (Pubitemid 34492564)
29. Epperly MW, Bray JA, Carlos TM, Prochownik E, Greenberger JS. Biology of marrow stromal cell lines derived from long-term bone marrow cultures of Trp53-deficient mice. Radiat Res 1999; 152:29-40. (Pubitemid 29296243)
30. Epperly MW, Bernarding M, Gretton J, Jefferson M, Nie S, Greenberger JS. Overexpression of the transgene for manganese superoxide dismutase (MnSOD) in 32D cl 3 cells prevents apoptosis induction by TNF-alpha, IL-3 withdrawal, and ionizing radiation. Exp Hematol 2003; 31:465-74. (Pubitemid 36793952)
31. Epperly MW, Gretton JA, DeFilippi SJ, Greenberger JS, Sikora CA, Liggit D, et al. Modulation of radiation-induced cytokine elevation associated with esophagitis and esophageal stricture by manganese superoxide dismutase-plasmid/liposome (SOD2-PL) gene therapy. Radiat Res 2001; 155:2-14. (Pubitemid 32125734)
32. Rajagopalan MS, Gupta K, Epperly MW, Franicola D, Zhang X, Wang H, et al. The mitochondria-targeted nitroxide JP4-039 augments potentially lethal irradiation damage repair. In Vivo 2009; 23:717-26.
33. Epperly MW, Goff J, Li S, Gao X, Wipf P, Wang H, et al. Intraesophageal administration of GS-nitroxide (JP4-039) protects against ionizing irradiation-induced esophagitis. In Vivo 2010; 24:811-21.
34. Ulrich G, Ziessel R, Harriman A. The chemistry of fluorescent bodipy dyes: versatility unsurpassed. Angew Chem Int Ed 2008; 47:1184-201.
35. Frantz MC, Forbeck EM, Davoren JE, Wang Z, Epperly MW, Greenberger JS, et al. Synthesis and biological analysis of mitochondria-targeted nitroxide conjugates based on Gramacidin S. J Am Chem Soc. Forthcoming.
36. Epperly MW, Osipov AN, Martin I, Kawai K, Borisenkko GG, Jefferson M, et al. Ascorbate as a ''redox-sensor'' and protector against irradiation-induced oxidative stress in 32D cl 3 hematopoietic cells and subclones overexpressing human manganese superoxide dismutase. Int J Radiat Oncol Biol Phys 2004; 58:851
37. Epperly MW, Wegner R, Kanai AJ, Kagan V, Greenberger EE, Nie S, et al. Irradiated murine oral cavity orthotopic tumor antioxidant pool destabilization by MnSOD-plasmid liposome gene therapy mediates tumor radiosensitization. Radiat Res 2007; 267:289-97. (Pubitemid 351292540)
38. Fagerlie S, Lensch MW, Pang Q, Bagby GC Jr. The Fanconi anemia group C gene product: signaling functions in hematopoietic cells. Exp Hematol 2001; 29:1371-81. (Pubitemid 34007613)
39. Park JW, Pitot HC, Strati K, Spardy N, Duensing S, Grompe M, et al. Deficiencies in the Fanconi anemia DNA damage response pathway increase sensitivity to HPV-associated head and neck cancer. Cancer Res 2010; 70:9959-68.
40. Tarhini AA, Belani C, Luketich JD, Ramalingam SS, Argiris A, Gooding W, et al. A phase I study of concurrent chemotherapy (Paclitaxel and Carboplatin) and thoracic radiotherapy with swallowed manganese superoxide dismutase (MnSOD) plasmid liposome (PL) protection in patients with locally advanced stage III non-small cell lung cancer. Hum Gene Ther 2011; 22:336-43.
41. Guo HL, Seixas-Silva JA, Epperly MW, Gretton JE, Shin DM, Greenberger JS. Prevention of irradiation-induced oral cavity mucositis by plasmid/liposome delivery of the human manganese superoxide dismutase (MnSOD) transgene. Radiat Res 2003; 159:361-70. (Pubitemid 36314951)
42. Zhang QS, Marquez-Loza L, Eaton L, Duncan AW, Goldman DC, Anur P, et al. Fancd2-/- mice have hematopoietic defects that can be partially corrected by Resveratrol. Blood 2010; 116:5140-51.
43. Li CY, Lee JS, Ko YG, Kim JI, Seo JS. Heat shock protein 70 inhibits apoptosis downstream of cytochrome c release and upstream of caspase-3 activation. J Biol Chem 2000; 275:25665-71.
44. Rathbun RK, Christianson TA, Faulkner GR, Jones G, Keeble W, O'Dwyer M, et al. Interferon-gamma-induced apoptotic responses of Fanconi anemia group C hematopoietic progenitor cells involve caspase 8-dependent activation of caspase 3 family members. Blood 2000; 96:4204-11.
45. Simon MM, Reikerstorfer A, Schwarz A, Krone C, Luger TA, Jäättelä M, et al. Heat shock protein 70 overexpression affects the response to ultraviolet light in murine fibroblasts. Evidence for increased cell viability and suppression of cytokine release. J Clin Invest 1995; 95:926-33.
46. Pang Q, Keeble W, Christianson TA, Faulkner GR, Bagby GC. FANCC interacts with Hsp70 to protect hematopoietic cells from IFN-gamma/TNF-alpha-mediated cytotoxicity. EMBO J 2001; 20:4478-89. (Pubitemid 32772042)
47. Pang Q, Christianson TA, Keeble W, Koretsky T, Bagby GC. The anti-apoptotic function of Hsp70 in the interferon-inducible double-stranded RNA-dependent protein kinase-mediated death signaling pathway requires the Fanconi anemia protein, FANCC. J Biol Chem 2002; 277:49638-43. (Pubitemid 36014405)
48. Jagus R, Joshi B, Barber GN. PKR, apoptosis and cancer. Int J Biochem Cell Biol 1999; 31:123-38. (Pubitemid 29094794)
49. Cumming RC, Lightfoot J, Beard K, Youssoufian H, O'Brien PJ, Buchwald M. Fanconi anemia group C protein prevents apoptosis in hematopoietic cells through redox regulation of GSTP1. Nat Med 2001; 7:814-20. (Pubitemid 32691636)
50. Pritsos CA, Sartorelli AC. Generation of reactive oxygen radicals through bioactivation of mitomycin antibiotics. Cancer Res 1986; 46:3528-32. (Pubitemid 16096902)
51. Zhang QS, Eaton L, Snyder ER, Houghtaling S, Mitchell JB, Finegold M, et al. Tempol protects against oxidative damage and delays epithelial tumor onset in Fanconi anemia mice. Cancer Res 2008; 68:1601-8. (Pubitemid 351346870)
52. van Zeeburg HJT, Snijders PJF, Pals G, Hermsen MAJA, Rooimans MA, Bagby G, et al. Generation and molecular characterization of head and neck squamous cell lines of Fanconi anemia patients. Cancer Res 2005; 65:1271-6. (Pubitemid 40270153)